Terms: = Kidney tumors AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Prognosis
9 results:
1. MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways.
Cui J; Yuan Y; Shanmugam MK; Anbalagan D; Tan TZ; Sethi G; Kumar AP; Lim LHK
Int J Biol Sci; 2021; 17(15):4254-4270. PubMed ID: 34803496
[No Abstract] [Full Text] [Related]
2. Individualized immune-related gene signature predicts immune status and oncologic outcomes in clear cell renal cell carcinoma patients.
Xiong Y; Liu L; Bai Q; Xia Y; Qu Y; Wang J; Guo J
Urol Oncol; 2020 Jan; 38(1):7.e1-7.e8. PubMed ID: 31653560
[TBL] [Abstract] [Full Text] [Related]
3. Baseline Edmonton Symptom Assessment System and survival in metastatic renal cell carcinoma.
Graham J; Gingerich J; Lambert P; Alamri A; Czaykowski P
Curr Oncol; 2018 Aug; 25(4):e319-e323. PubMed ID: 30111978
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features and outcomes in patients with late recurrence of renal cell carcinoma after radical surgery.
Kobayashi K; Saito T; Kitamura Y; Bilim V; Toba T; Kawasaki T; Hara N; Tanikawa T; Tomita Y
Int J Urol; 2016 Feb; 23(2):132-7. PubMed ID: 27688158
[TBL] [Abstract] [Full Text] [Related]
5. Statins and survival outcomes in patients with metastatic renal cell carcinoma.
McKay RR; Lin X; Albiges L; Fay AP; Kaymakcalan MD; Mickey SS; Ghoroghchian PP; Bhatt RS; Kaffenberger SD; Simantov R; Choueiri TK; Heng DY
Eur J Cancer; 2016 Jan; 52():155-62. PubMed ID: 26687834
[TBL] [Abstract] [Full Text] [Related]
6. Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
Nam SJ; Lee C; Park JH; Moon KC
Urol Oncol; 2015 Aug; 33(8):340.e9-16. PubMed ID: 26003625
[TBL] [Abstract] [Full Text] [Related]
7. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
Aronson DC; Hadley GP
Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
[TBL] [Abstract] [Full Text] [Related]
8. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.
Heng DY; Xie W; Regan MM; Harshman LC; Bjarnason GA; Vaishampayan UN; Mackenzie M; Wood L; Donskov F; Tan MH; Rha SY; Agarwal N; Kollmannsberger C; Rini BI; Choueiri TK
Lancet Oncol; 2013 Feb; 14(2):141-8. PubMed ID: 23312463
[TBL] [Abstract] [Full Text] [Related]
9. [Screening and identification analysis of serum protein biomarkers in nephroblastoma].
Wang JX; Yang SB; Liu QL; Dong R; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1259-63. PubMed ID: 19595180
[TBL] [Abstract] [Full Text] [Related]